Baxter International (BAX) Change in Accured Expenses (2009 - 2026)

Baxter International (BAX) has 18 years of Change in Accured Expenses data on file, last reported at $203.0 million in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $203.0 million, up 41.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $209.0 million (up 494.34% YoY), and the FY2025 annual result was $149.0 million, up 238.64% from the prior year.
• Change in Accured Expenses rose to $203.0 million in Q1 2026 per BAX's latest filing, from $180.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $554.0 million in Q4 2023 and troughed at -$396.0 million in Q4 2022.
• A 5-year average of $31.2 million and a median of $8.0 million in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses plunged 397.06% in 2023, then soared 301.68% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at -$396.0 million in 2022, then soared by 239.9% to $554.0 million in 2023, then plunged by 126.71% to -$148.0 million in 2024, then surged by 221.62% to $180.0 million in 2025, then gained by 12.78% to $203.0 million in 2026.
• Business Quant data shows BAX's Change in Accured Expenses at $203.0 million in Q1 2026, $180.0 million in Q4 2025, and -$182.0 million in Q3 2025.